Natural and adaptive IgM antibodies exhibited a potential to eliminate cancer cells by recognition of tumor-modified cell surface neo-antigens developed during tumorigenesis and to apply a direct cytotoxic effect to tumor cells by activating the complement system [36,37]. The gene discussed is CD40LG; the disease is neoplasm.